Drugs / PF-06409577
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02286882 | Nov 2014 → Jun 2015 | — | Pfizer | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-06409577 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02286882 ↗ |
| Route | Oral | “single oral doses of PF-06409577” NCT02286882 ↗ |